USPTO serial 87660540
GD3
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 15, 2019
- Examiner
- MUCHA, JOHN EVAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GD3?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Genesis Drug Discovery & Development, LLC
Hamilton, NJ
Other trademarks owned by Genesis Drug Discovery & Development, LLC
Genesis Drug Discovery & Development, LLC
Hamilton, NJ
Other trademarks owned by Genesis Drug Discovery & Development, LLC
Genesis Drug Discovery & Development, LLC
Hamilton, NJ
Other trademarks owned by Genesis Drug Discovery & Development, LLC
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina E. Brule
Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.5 Columbia CircleAlbany, NY 12203United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery | SECTION 8 - CANCELLED | Oct 24, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genesis Drug Discovery & Development, LLC
- Other trademarks owned by Genesis Drug Discovery & Development, LLC
- Other trademarks owned by Genesis Drug Discovery & Development, LLC
- Other trademarks in Class 042
- Similar marks named GD3
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 25, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 15, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 15, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 15, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 15, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 15, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 15, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 8, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 8, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 8, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 27, 2018 | IUAF | USE AMENDMENT FILED | — |
| Nov 27, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 29, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 3, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 3, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 14, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 20, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 20, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 20, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 20, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 20, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 7, 2017 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 4, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2017 | NWAP | NEW APPLICATION ENTERED | — |